Lessee, Operating Lease, Liability, to be Paid, Year Two in USD of Eledon Pharmaceuticals, Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Eledon Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and change rate from Q1 2019 to Q3 2025.
  • Eledon Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending September 30, 2025 was $293K, a 48.7% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Eledon Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $293K +$96K +48.7% Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $293K +$96K +48.7% Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $293K Mar 31, 2025 10-Q/A 2025-08-14
Q4 2024 $403K Dec 31, 2024 10-K/A 2025-08-14
Q3 2024 $197K Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $197K Jun 30, 2024 10-Q 2024-08-19
Q4 2022 $388K +$176K +83% Dec 31, 2022 10-K 2023-03-30
Q3 2022 $389K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $200K Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $200K Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $212K Dec 31, 2021 10-K 2022-03-24
Q1 2020 $146K -$42K -22.3% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $146K Dec 31, 2019 10-K 2020-03-17
Q3 2019 $188K Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $188K Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $188K Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.